Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Pharmacological Interventions for Preventing Anthracycline-Induced Clinical and Subclinical Cardiotoxicity: A Network Meta-Analysis of Metastatic Breast Cancer Publisher Pubmed



Ghasemi K1, 2 ; Vaseghi G3 ; Mansourian M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Epidemiology and Biostatistics, Health School, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Student Research Committee, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Applied Physiology Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medicine Sciences, Isfahan, Iran

Source: Journal of Oncology Pharmacy Practice Published:2021


Abstract

Objective: Doxorubicin- and epirubicin-induced cardiotoxicities are life threatening for those suffering from breast cancer. Comparing the effects of different strategies on the prevention of these agent-induced cardiotoxicities remains unexplored. Data sources: A comprehensive review of clinical trials was performed on the prevention of epirubicin- and/or doxorubicin-induced cardiotoxicity in HER2-positive metastatic breast cancer patients. The reduction in ejection fraction was directed at evaluating cardiac toxicity. Data summary: Fourteen articles evaluated cardiotoxicity as a condition among 2945 individuals, evaluating doxorubicin, epirubicin, Liposomal Doxorubicin (LD), Pegylated Liposomal Doxorubicin (PLD), dexrazoxane plus doxorubicin or epirubicin, and Angiotensin-Converting Enzyme Inhibitors (ACEIs) plus doxorubicin. Pooled Odds Ratio (OR) of 0.043 with a 95% credible interval (CrI) between 0.005 and 0.22 indicated that the dexrazoxane plus epirubicin reduced the number of cardiac events compared with doxorubicin. Furthermore, doxorubicin and epirubicin represented the most effective interventions with a 52% probability of success. Also, the best treatment for reducing Congestive Heart Failure (CHF) was dexrazoxane plus epirubicin with a probability of 43%. For the Left Ventricular Ejection Fraction (LVEF) reduction outcome, ACEIs plus doxorubicin was ranked first with a success probability of 61.2% and they could significantly prevent the reduction in LVEF compared with LD, epirubicin, or doxorubicin. Conclusion: Our data suggested that angiotensin-converting enzyme inhibitors and dexrazoxane plus epirubicin were the most effective interventions for preventing cardiotoxicity and CHF. However, ACEIs plus doxorubicin was the best treatment for preventing LVEF reduction. © The Author(s) 2020.
Related Docs
View other Related Docs
1. Network Meta-Analysis Application in Comparison of Clinical Trial Studies, Journal of Health System Research (2020)
2. Anthracycline Associated Disturbances of Cardiovascular Homeostasis, Current Problems in Cardiology (2022)
3. Cardioprotective Potential of Protocatechuic Acid Against Doxorubicin-Induced Cardiotoxicity in Rats, Research in Pharmaceutical Sciences (2025)
4. Possibilities of Dapagliflozin-Induced Cardioprotection on Doxorubicin + Cyclophosphamide Mode of Chemotherapy-Induced Cardiomyopathy, International Journal of Cardiology (2023)
5. Doxorubicin-Related Cardiotoxicity: Review of Fundamental Pathways of Cardiovascular System Injury, Cardiovascular Pathology (2024)
6. Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity; [Сравнительная Характеристика Кардиопротекторных Эффектов Дапаглифлозина И Триметазидина На Модели Доксорубицин-Циклофосфамидной Кардиотоксичности], Innovative Medicine of Kuban (2023)
7. Doxorubicin and Cyclophosphamide Mode of Chemotherapy-Related Cardiomyopathy: Review of Preclinical Model, Current problems in cardiology (2025)
8. Protective Effects of Protocatechuic Acid Against Doxorubicin- and Arsenic Trioxide-Induced Toxicity in Cardiomyocytes, Research in Pharmaceutical Sciences (2023)
Experts (# of related papers)
View all Related Experts
Nizal Sarrafzadegan (6)
Leila Safaeian (4)
Other Related Docs
9. Synthesis, Analysis and Biological Evaluation of Novel Steroidal Estrogenic Prodrugs for the Treatment of Breast Cancer, Pharmaceutical Biology (2004)
10. Trimetazidine As a Modifier of Chemotherapy-Induced Cardiovascular Redox-Homeostasis Disturbances, Kardiologija v Belarusi (2022)
11. Alterations in the Echocardiographic Variables of the Right Ventricle in Asymptomatic Patients With Breast Cancer During Anthracycline Chemotherapy, Postgraduate Medical Journal (2017)
12. Ac-Mode of Chemotherapy As a Trigger of Cardiac Syndrome X: A Case Study, Current Problems in Cardiology (2022)
13. Andrographolide Protects Against Doxorubicin-And Arsenic Trioxide-Induced Toxicity in Cardiomyocytes, Molecular Biology Reports (2023)
14. Cardioprotective Effect of Vanillic Acid Against Doxorubicin-Induced Cardiotoxicity in Rat, Research in Pharmaceutical Sciences (2020)
15. Diagnostic Value of Nonacid Nucleic Blood Tumor Marker Panels in Early Diagnosing Breast Cancer: A Systematic Review and Network Meta-Analysis, Disease Markers (2022)
16. Genetically Engineered Mouse Embryonic Stem Cell-Derived Cardiomyocytes As a Suitable Model on Drugs Toxicity Assessment in Vitro, Journal of Isfahan Medical School (2014)
17. Prevalence of Major Cardiac Events of Anthracycline-Induced Cardiotoxicity in Southwestern Iran: Different Response Patterns to Cumulative Dose, Current Drug Therapy (2020)
18. An Engineered Non-Erythropoietic Erythropoietin-Derived Peptide, Ara290, Attenuates Doxorubicin Induced Genotoxicity and Oxidative Stress, Toxicology in Vitro (2020)
19. Cytotoxic Effect of Pluronic F127-Poly (Methyl Vinyl Ether-Alt-Maleic Acid) Micelles Loaded With Doxorubicin on Mcf-7 Cells, Journal of Isfahan Medical School (2013)
20. Effects of Allopurinol on the Left Ventricular Ejection Fraction in Patients With Left Ventricular Failure, Journal of Isfahan Medical School (2007)
21. The Prevention of Cisplatin-Induced Nephrotoxicity: A General Consensus Statement of a Group of Oncologist-Hematologists, Adult and Pediatric Nephrologists, Radiation Oncologists, Clinical Pathologists, Clinical Pharmacologists, and Renal Physiologists on Cisplatin Therapy in Cancer Patients, International Journal of Preventive Medicine (2022)
22. Evaluation of Ecg Changes After Radiotherapy of Left Chest Wall by Electron in Patients With Left Breast Cancer Who Receive Anthracycline Based Chemotherapy Following Mastectomy, Journal of Research in Medical Sciences (2005)
23. Antiapoptotic and Anti-Inflammatory Effects of Pparγ Agonist, Pioglitazone, Reversed Dox-Induced Cardiotoxicity Through Mediating of Mir-130A Downregulation in C57bl/6 Mice, Journal of Biochemical and Molecular Toxicology (2022)
24. The Cytotoxicity of 27-Hydroxycholesterol in Mcf-7 and Mda-Mb-231, Advanced Biomedical Research (2023)
25. Evaluation of Mir-146A As a Potential Biomarker for Diagnosis of Cardiotoxicity Induced by Chemotherapy in Patients With Breast Cancer, Journal of Research in Medical Sciences (2025)
26. Evaluation of Expression Level of Mir-3135B-5P in Blood Samples of Breast Cancer Patients Experiencing Chemotherapy-Induced Cardiotoxicity, Indian Journal of Clinical Biochemistry (2023)
27. Severe Mitral Regurgitation, an Unusual Manifestation of Chemotherapy-Induced Cardiotoxicity, Journal of Research in Medical Sciences (2017)